165 related articles for article (PubMed ID: 18489439)
1. Molecular modeling and docking analysis of Entamoeba histolytica glyceraldehyde-3 phosphate dehydrogenase, a potential target enzyme for anti-protozoal drug development.
Singh S; Malik BK; Sharma DK
Chem Biol Drug Des; 2008 Jun; 71(6):554-62. PubMed ID: 18489439
[TBL] [Abstract][Full Text] [Related]
2. Computational study of glyceraldehyde-3-phosphate dehydrogenase of Entamoeba histolytica: implications for structure-based drug design.
Kundu S; Roy D
J Biomol Struct Dyn; 2007 Aug; 25(1):25-33. PubMed ID: 17676935
[TBL] [Abstract][Full Text] [Related]
3. Conformational changes in Leishmania mexicana glyceraldehyde-3-phosphate dehydrogenase induced by designed inhibitors.
Suresh S; Bressi JC; Kennedy KJ; Verlinde CL; Gelb MH; Hol WG
J Mol Biol; 2001 Jun; 309(2):423-35. PubMed ID: 11371162
[TBL] [Abstract][Full Text] [Related]
4. Evidence for the two phosphate binding sites of an analogue of the thioacyl intermediate for the Trypanosoma cruzi glyceraldehyde-3-phosphate dehydrogenase-catalyzed reaction, from its crystal structure.
Castilho MS; Pavão F; Oliva G; Ladame S; Willson M; Périé J
Biochemistry; 2003 Jun; 42(23):7143-51. PubMed ID: 12795610
[TBL] [Abstract][Full Text] [Related]
5. Selective tight binding inhibitors of trypanosomal glyceraldehyde-3-phosphate dehydrogenase via structure-based drug design.
Aronov AM; Verlinde CL; Hol WG; Gelb MH
J Med Chem; 1998 Nov; 41(24):4790-9. PubMed ID: 9822549
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of Leishmania mexicana glycosomal glyceraldehyde-3-phosphate dehydrogenase in a new crystal form confirms the putative physiological active site structure.
Kim H; Hol WG
J Mol Biol; 1998 Apr; 278(1):5-11. PubMed ID: 9571030
[TBL] [Abstract][Full Text] [Related]
7. Entamoeba histolytica: ADP-ribosylation of secreted glyceraldehyde-3-phosphate dehydrogenase.
Alvarez AH; Martinez-Cadena G; Silva ME; Saavedra E; Avila EE
Exp Parasitol; 2007 Dec; 117(4):349-56. PubMed ID: 17586498
[TBL] [Abstract][Full Text] [Related]
8. New 3-piperonylcoumarins as inhibitors of glycosomal glyceraldehyde-3-phosphate dehydrogenase (gGAPDH) from Trypanosoma cruzi.
de Marchi AA; Castilho MS; Nascimento PG; Archanjo FC; del Ponte G; Oliva G; Pupo MT
Bioorg Med Chem; 2004 Sep; 12(18):4823-33. PubMed ID: 15336261
[TBL] [Abstract][Full Text] [Related]
9. Entamoeba histolytica: computer-assisted modeling of phosphofructokinase for the prediction of broad-spectrum antiparasitic agents.
Byington CL; Dunbrack RL; Whitby FG; Cohen FE; Agabian N
Exp Parasitol; 1997 Nov; 87(3):194-202. PubMed ID: 9371084
[TBL] [Abstract][Full Text] [Related]
10. Structural analysis of human liver glyceraldehyde-3-phosphate dehydrogenase.
Ismail SA; Park HW
Acta Crystallogr D Biol Crystallogr; 2005 Nov; 61(Pt 11):1508-13. PubMed ID: 16239728
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for selective inhibition of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase: molecular docking and 3D QSAR studies.
Guido RV; Oliva G; Montanari CA; Andricopulo AD
J Chem Inf Model; 2008 Apr; 48(4):918-29. PubMed ID: 18303835
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of glyceraldehyde-3-phosphate dehydrogenase from Plasmodium falciparum at 2.25 A resolution reveals intriguing extra electron density in the active site.
Robien MA; Bosch J; Buckner FS; Van Voorhis WC; Worthey EA; Myler P; Mehlin C; Boni EE; Kalyuzhniy O; Anderson L; Lauricella A; Gulde S; Luft JR; DeTitta G; Caruthers JM; Hodgson KO; Soltis M; Zucker F; Verlinde CL; Merritt EA; Schoenfeld LW; Hol WG
Proteins; 2006 Mar; 62(3):570-7. PubMed ID: 16345073
[TBL] [Abstract][Full Text] [Related]
13. Current and future perspectives on the chemotherapy of the parasitic protozoa Trichomonas vaginalis and Entamoeba histolytica.
Moya IA; Su Z; Honek JF
Future Med Chem; 2009 Jul; 1(4):619-43. PubMed ID: 21426030
[TBL] [Abstract][Full Text] [Related]
14. Discovery of Entamoeba histolytica hexokinase 1 inhibitors through homology modeling and virtual screening.
Saucedo-Mendiola ML; Salas-Pacheco JM; Nájera H; Rojo-Domínguez A; Yépez-Mulia L; Avitia-Domínguez C; Téllez-Valencia A
J Enzyme Inhib Med Chem; 2014 Jun; 29(3):325-32. PubMed ID: 23534932
[TBL] [Abstract][Full Text] [Related]
15. Identification of electronic and structural descriptors of adenosine analogues related to inhibition of leishmanial glyceraldehyde-3-phosphate dehydrogenase.
Lozano NB; Oliveira RF; Weber KC; Honorio KM; Guido RV; Andricopulo AD; Da Silva AB
Molecules; 2013 Apr; 18(5):5032-50. PubMed ID: 23629757
[TBL] [Abstract][Full Text] [Related]
16. Design of Inhibitors for Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH) Enzyme of
Alves KMA; Cardoso FJB; Honorio KM; de Molfetta FA
Med Chem; 2020; 16(6):784-795. PubMed ID: 31309897
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel Trypanosoma cruzi glyceraldehyde-3-phosphate dehydrogenase inhibitors.
Freitas RF; Prokopczyk IM; Zottis A; Oliva G; Andricopulo AD; Trevisan MT; Vilegas W; Silva MG; Montanari CA
Bioorg Med Chem; 2009 Mar; 17(6):2476-82. PubMed ID: 19254846
[TBL] [Abstract][Full Text] [Related]
18. A structural model for chorismate synthase from Mycobacterium tuberculosis in complex with coenzyme and substrate.
Fernandes CL; Breda A; Santos DS; Basso LA; Souza ON
Comput Biol Med; 2007 Feb; 37(2):149-58. PubMed ID: 16584721
[TBL] [Abstract][Full Text] [Related]
19. Glycolysis in Entamoeba histolytica. Biochemical characterization of recombinant glycolytic enzymes and flux control analysis.
Saavedra E; Encalada R; Pineda E; Jasso-Chávez R; Moreno-Sánchez R
FEBS J; 2005 Apr; 272(7):1767-83. PubMed ID: 15794763
[TBL] [Abstract][Full Text] [Related]
20. Structure-based design of submicromolar, biologically active inhibitors of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase.
Aronov AM; Suresh S; Buckner FS; Van Voorhis WC; Verlinde CL; Opperdoes FR; Hol WG; Gelb MH
Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4273-8. PubMed ID: 10200252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
